CORCEPT THERAPEUTICS INC (CORT) scores 69 out of 100 on boothcheck's 11-model valuation framework. Verdict: Fair The estimated fair value is 31.11, representing a 26% premium to fair value. Quantitative score: 73/100. Qualitative score: 60/100.
Analysis includes bear, base, and bull fair value targets using DCF, Graham, regression, and 8 other valuation models.